Medical University of South Carolina
musc.eduLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
857
Active
187
Phase 3
36
Total enrollment
180,384
Pipeline matrix
Showing 40 of 69 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Varenicline Pill | — | — | — | — | — | 1 | |
| Progesterone supplementation | — | — | — | — | — | 1 | |
| Preoperative midazolam | — | — | — | — | — | 1 | |
| Daily Vitamin D3 | — | — | — | — | — | 1 | |
| Daily placebo | — | — | — | — | — | 1 | |
| Bolus vitamin D3 | — | — | — | — | — | 1 | |
| Bolus placebo | — | — | — | — | — | 1 | |
| Biologic Agents | — | — | — | — | — | 1 | |
| Remimazolam besylate | — | — | — | — | — | 1 | |
| Nicotine replacement therapy patches | — | — | — | — | — | 1 | |
| Oral nicotine pouches | — | — | — | — | — | 1 | |
| propofol | — | — | — | — | 2 | ||
| IV N-acetylcysteine | — | — | — | — | — | 1 | |
| IV Placebo | — | — | — | — | — | 1 | |
| NAC and taVNS | — | — | — | — | — | 1 | |
| sterile water and inactive taVNS | — | — | — | — | — | 1 | |
| Methadone | — | — | — | — | — | 1 | |
| Methadone Hydrochloride | — | — | — | — | — | 1 | |
| Varenicline | — | — | 8 | ||||
| Naltrexone hydrochloride | — | — | — | — | 2 | ||
| bevacizumab | — | — | — | — | — | 3 | |
| oxaliplatin | — | — | — | — | — | 3 | |
| Rapamycin | — | — | — | — | 2 | ||
| Carboplatin | — | — | — | — | 2 | ||
| Paclitaxel | — | — | — | — | — | 2 | |
| Pembrolizumab | — | — | — | — | 2 | ||
| sirolimus | — | — | — | — | — | 2 | |
| Cannabidiol oral solution | — | — | — | — | — | 1 | |
| Indocyanine Green | — | — | — | — | — | 1 | |
| Buprenorphine Patch | — | — | — | — | — | 1 | |
| Liposomal Irinotecan | — | — | — | — | — | 1 | |
| 5-Fluorouracil | — | — | — | — | — | 1 | |
| Leucovorin | — | — | — | — | — | 1 | |
| Nab-paclitaxel | — | — | — | — | — | 1 | |
| Citicoline | — | — | — | — | — | 1 | |
| Bupropion Hydrochloride Extended-release | — | — | — | — | — | 1 | |
| Simvastatin 40mg | — | — | — | — | — | 1 | |
| Hydroxychloroquine, Metformin, Sirolimus | — | — | — | — | — | 1 | |
| Hydroxychloroquine, Metformin, Sirolimus, Dasatanib | — | — | — | — | — | 1 | |
| Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir | — | — | — | — | — | 1 |
29 more active programs hidden
Next readouts
- 2022-12-31
- 2026-04-29
- 2026-06-01
- 2026-06-30
- 2026-07-31
- 2026-10
- 2026-11-06
- 2026-11-25
- 2026-12
- 2026-12-28
Top conditions
- Stroke43
- Depression32
- Smoking Cessation22
- Nicotine Dependence20
- Smoking20
- Alcohol Use Disorder19
- Alcohol Dependence18
- Prostate Cancer18
Frequently asked questions about Medical University of South Carolina
- How many clinical trials does Medical University of South Carolina have on ClinicalTrials.gov?
- Medical University of South Carolina is listed as the lead sponsor on 857 clinical trials in ClinicalTrials.gov, 187 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medical University of South Carolina's trials are in Phase 3?
- 36 of Medical University of South Carolina's trials are in Phase 3, spread across 69 active drug programs.
- What therapeutic areas does Medical University of South Carolina focus on?
- Medical University of South Carolina's most-studied conditions on ClinicalTrials.gov are Stroke, Depression, Smoking Cessation, Nicotine Dependence, Smoking.
- When are Medical University of South Carolina's next clinical trial readouts?
- Medical University of South Carolina has 10 upcoming primary-completion readouts tracked here; the soonest is “Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection”, expected around 2022-12-31.